Oct 19, 2022 / 01:30PM GMT
Operator
Good day, ladies and gentlemen. Welcome to the Sartorius and Sartorius Stedim Biotech Conference Call on the 9 Months 2022 Results. Today's conference is being recorded. It is my pleasure, and I would now like to turn the conference over to Dr. Joachim Kreuzburg, CEO. Please go ahead, sir.
Joachim Kreuzburg - Sartorius Aktiengesellschaft - Chairman of Executive Board & CEO
Thank you very much, and hello and good day also from my side. Together with our CFO, Rainer Lehmann, I will now walk you through the results for the first 9 months of 2022 for both the Sartorius Group and Sartorius Stedim Biotech. As always, I will kick it off by talking a little bit about the highlights of our business development this year so far. Then also briefly, I'll remind everybody about the key features of the acquisition that we have been able to close by end of last month. And then I will hand over to Rainer on the numbers for the Sartorius Group.
So I think, overall, we have seen a good third quarter, pretty much with the same set of numbers as we have seen for the
Q3 2022 Sartorius AG Earnings Call Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers